Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$113,640,243
+$113,640,243 QoQ
Shares Held
1,525,782
Ownership
0.781%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#32
of 462 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2026CallValue
$521,360
CallShares
7,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. BBIO ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in BBIO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $521,360 | 7,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $113,640,243 | 1,525,782 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,752,536 | 23,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,752,536 | 23,600 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $290,662 | 3,800 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $290,662 | 3,800 | Put | Defined | 2026-02-17 | |
| 2025-03-31 | $1,037,100 | 30,000 | Put | Defined | 2025-07-21 | |
| 2025-03-31 | $3,457,000 | 100,000 | Call | Defined | 2025-07-21 | |
| 2025-03-31 | $6,871,824 | 198,780 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $1,646,400 | 60,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $891,100 | 35,000 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $759,900 | 30,000 | Call | Defined | 2024-09-16 | |
| 2023-12-31 | $2,018,500 | 50,000 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $138,838 | 5,265 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,146,792 | 66,674 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,644,304 | 99,174 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $580,300 | 35,000 | Put | Defined | 2023-05-15 | |
| 2021-12-31 | $512,076 | 30,700 | Call | Defined | 2022-02-14 | |
| 2021-12-31 | $870,696 | 52,200 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $839,204 | 50,312 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||